Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy.

Grotta, J C; Chiu, D; Lu, M; Patel, S; Levine, S R; Tilley, B C; Brott, T G; Haley, E C; Lyden, P D; Kothari, R; Frankel, M; Lewandowski, C A; Libman, R; Kwiatkowski, T; Broderick, J P; Marler, J R; Corrigan, J; Huff, S; Mitsias, P; Talati, S; Tanne, D

Grotta, J C; Chiu, D; Lu, M; Patel, S; Levine, S R; Tilley, B C; Brott, T G; Haley, E C; Lyden, P D; Kothari, R; Frankel, M; Lewandowski, C A; Libman, R; Kwiatkowski, T; Broderick, J P; Marler, J R; Corrigan, J; Huff, S; Mitsias, P; Talati, S; Tanne, D.

Affiliation

Grotta JC; Department of Neurology, University of Texas-Houston Medical School, Houston, Texas, USA. jgrotta@neuro.med.uth.tmc.edu

Stroke ; 30(8): 1528-33, 1999 Aug.

Article in En | MEDLINE | ID: mdl-10436095

Subject(s)

Cerebrovascular Disorders/diagnostic imaging; Fibrinolytic Agents/therapeutic use; Tissue Plasminogen Activator/therapeutic use; Tomography, X-Ray Computed; Cerebrovascular Disorders/drug therapy; Confidence Intervals; Double-Blind Method; Fibrinolytic Agents/administration & dosage; Humans; Injections, Intravenous; Observer Variation; Recombinant Proteins; Reproducibility of Results; Tissue Plasminogen Activator/administration & dosage; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tomography, X-Ray Computed / Cerebrovascular Disorders / Tissue Plasminogen Activator / Fibrinolytic Agents Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Stroke Year: 1999 Document type: Article

Search on Google

XML

PubMed Links